REALASA: Real-world effectiveness assessment of first-line 5-ASA for the treatment of Ulcerative Colitis in Sweden

被引：0
|
作者：
Christophersen, B. [1 ]
Nielsen, L. [2 ]
Landeira, M. [3 ]
Guedes, S. [4 ]
机构：
[1] Ferring Pharmaceut Inc, Med Affairs, Copenhagen, Denmark
[2] Ferring Pharmaceut Inc, Stat, Copenhagen, Denmark
[3] Ferring Pharmaceut Inc, Hlth Econ & Outcomes Res, Copenhagen, Denmark
[4] Ferring Pharmaceut Inc, Real World Evidence, Copenhagen, Denmark
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.0907
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0733
引用
收藏
页码：I1423 / I1423
页数：1
相关论文
共 50 条
  • [1] 5-ASA in ulcerative colitis: Improving treatment compliance
    Prantera, Cosimo
    Rizzi, Marina
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (35) : 4353 - 4355
  • [2] 5-ASA in ulcerative colitis:Improving treatment compliance
    Cosimo Prantera
    Marina Rizzi
    World Journal of Gastroenterology, 2009, 15 (35) : 4353 - 4355
  • [3] Is 5-ASA Still the Treatment of Choice for Ulcerative Colitis?
    Cottone, Mario
    Renna, Sara
    Modesto, Irene
    Orlando, Ambrogio
    CURRENT DRUG TARGETS, 2011, 12 (10) : 1396 - 1405
  • [4] Real World Experience With Vedolizumab as First-Line Therapy for the Treatment of Ulcerative Colitis
    Ritter, Timothy E.
    Mehta, Samantha A.
    Van Anglen, Lucinda J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S439 - S439
  • [5] COST-EFFECTIVENESS OF 5-ASA THERAPY IN COMBINATION WITH BIOLOGICS OR TOFACITINIB IN THE TREATMENT OF ULCERATIVE COLITIS
    Shaffer, Seth
    Huang, Elbert
    Patel, Shivani
    Rubin, David T.
    GASTROENTEROLOGY, 2020, 158 (06) : S659 - S660
  • [6] COMBINED 5-ASA BUTYRATE TREATMENT IN DISTAL ULCERATIVE-COLITIS
    VERNIA, P
    CITTADINI, M
    FRIERI, G
    CAPRILLI, R
    TORSOLI, A
    GASTROENTEROLOGY, 1993, 104 (04) : A796 - A796
  • [7] REAL-WORLD EFFECTIVENESS OF USTEKINUMAB IN ULCERATIVE COLITIS
    Hong, Simon
    Zullow, Samantha
    Axelrad, Jordan
    Chang, Shannon
    Hudesman, David
    INFLAMMATORY BOWEL DISEASES, 2020, 26 : S73 - S74
  • [8] Real-World Effectiveness and Onset of Action of Vedolizumab as a First-Line Biologic in Biologic-Naïve Patients With Ulcerative Colitis
    Anyanwu, Precious A.
    Van Anglen, Lucinda J.
    Chou, Chiahung
    Sanchirico, Marie
    Ritter, Timothy E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S876 - S877
  • [9] REAL-WORLD EFFECTIVENESS OF USTEKINUMAB IN ULCERATIVE COLITIS
    Hong, Simon
    Zullow, Samantha
    Axelrad, Jordan
    Chang, Shannon
    Hudesman, David
    GASTROENTEROLOGY, 2020, 158 (03) : S120 - S120
  • [10] Real-World Comparison of Effectiveness, Treatment Persistence, and Safety of First-Line Advanced Therapies at 1 Year for Ulcerative Proctitis
    Dalal, Rahul S.
    Clarke, Lindsay M.
    Carlin, Alex
    Cabral, Heidy
    Allegretti, Jessica R.
    INFLAMMATORY BOWEL DISEASES, 2024,
12345